VURZARRO

Serial Number 90714817
606

Registration Progress

Application Filed
May 17, 2021
Under Examination
Feb 8, 2022
Approved for Publication
Dec 14, 2021
Published for Opposition
Dec 14, 2021
Registered

Trademark Image

VURZARRO

Basic Information

Serial Number
90714817
Filing Date
May 17, 2021
Published for Opposition
December 14, 2021
Abandonment Date
September 9, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 9, 2024
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Danielle R. Weitzman

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Sep 9, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 9, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 25, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 3, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 3, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 3, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 25, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 17, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 17, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 29, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 29, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 29, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 8, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 14, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 14, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 24, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 24, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 24, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 9, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 28, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 14, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification

International Classes
005